Manzo Pharmaceuticals, Inc. (MNZO)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Jun 17, 2025
Manzo Pharmaceuticals Company Description
Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies.
The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies.
It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014.
Manzo Pharmaceuticals, Inc. was incorporated in 1980 and is based in Milford, Pennsylvania.
Manzo Pharmaceuticals, Inc.
| Country | United States |
| Founded | 1980 |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 12 |
| CEO | Kenneth Manzo |
Contact Details
Address: PO Box 107 Milford, Nevada 18337 United States | |
| Phone | 570-249-6000 |
| Website | lactofreedom.com |
Stock Details
| Ticker Symbol | MNZO |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US56510D1063 |
| SIC Code | 1311 |
Key Executives
| Name | Position |
|---|---|
| Kenneth Manzo | Chairman and Chief Executive Officer |